| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Marrow Diseases | 1 | 2021 | 45 | 0.670 |
Why?
|
| Interleukin-3 Receptor alpha Subunit | 1 | 2016 | 11 | 0.480 |
Why?
|
| Hodgkin Disease | 3 | 2026 | 308 | 0.440 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 91 | 0.430 |
Why?
|
| T-Lymphocytes | 3 | 2019 | 1713 | 0.410 |
Why?
|
| Translocation, Genetic | 3 | 2025 | 348 | 0.370 |
Why?
|
| Burkitt Lymphoma | 2 | 2024 | 132 | 0.350 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2025 | 850 | 0.340 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 2 | 2024 | 156 | 0.340 |
Why?
|
| Biomarkers, Tumor | 3 | 2024 | 1617 | 0.310 |
Why?
|
| Hematologic Neoplasms | 2 | 2022 | 311 | 0.290 |
Why?
|
| Primary Myelofibrosis | 3 | 2018 | 53 | 0.280 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2022 | 292 | 0.270 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2025 | 40 | 0.260 |
Why?
|
| Fanconi Anemia | 2 | 2018 | 48 | 0.260 |
Why?
|
| Neoplasms | 1 | 2021 | 2957 | 0.240 |
Why?
|
| Reed-Sternberg Cells | 1 | 2026 | 19 | 0.240 |
Why?
|
| Hyperbilirubinemia, Neonatal | 1 | 2025 | 5 | 0.230 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2017 | 130 | 0.230 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2025 | 13 | 0.230 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2025 | 243 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2025 | 58 | 0.210 |
Why?
|
| Cellular Senescence | 1 | 2026 | 218 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2024 | 168 | 0.200 |
Why?
|
| Hemoglobinopathies | 1 | 2023 | 15 | 0.200 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2025 | 156 | 0.190 |
Why?
|
| Repressor Proteins | 2 | 2025 | 776 | 0.190 |
Why?
|
| Child | 17 | 2026 | 26218 | 0.190 |
Why?
|
| Pityriasis Lichenoides | 1 | 2022 | 1 | 0.190 |
Why?
|
| Lymphomatoid Papulosis | 1 | 2022 | 3 | 0.190 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 1 | 2022 | 19 | 0.190 |
Why?
|
| Herpesvirus 4, Human | 3 | 2022 | 641 | 0.190 |
Why?
|
| Histiocytosis | 1 | 2022 | 18 | 0.180 |
Why?
|
| Rubinstein-Taybi Syndrome | 1 | 2022 | 16 | 0.180 |
Why?
|
| Lymphoma, Large-Cell, Anaplastic | 1 | 2022 | 50 | 0.180 |
Why?
|
| Blood Platelet Disorders | 1 | 2022 | 14 | 0.180 |
Why?
|
| Fanconi Anemia Complementation Group D2 Protein | 2 | 2018 | 13 | 0.170 |
Why?
|
| Biology | 1 | 2021 | 25 | 0.170 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2022 | 153 | 0.160 |
Why?
|
| Liver Failure, Acute | 1 | 2021 | 96 | 0.160 |
Why?
|
| Humans | 31 | 2026 | 130870 | 0.160 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 80 | 0.160 |
Why?
|
| Sarcoma, Myeloid | 1 | 2019 | 11 | 0.150 |
Why?
|
| Lymphoma, B-Cell | 1 | 2021 | 146 | 0.150 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2019 | 15 | 0.150 |
Why?
|
| Leukemia, Myelomonocytic, Juvenile | 1 | 2019 | 11 | 0.150 |
Why?
|
| Azacitidine | 1 | 2019 | 52 | 0.150 |
Why?
|
| Hematopoiesis | 2 | 2022 | 212 | 0.150 |
Why?
|
| Anemia, Sickle Cell | 1 | 2023 | 331 | 0.150 |
Why?
|
| Eosinophilia | 1 | 2020 | 108 | 0.150 |
Why?
|
| Lymphoma | 1 | 2022 | 328 | 0.150 |
Why?
|
| Metal Metabolism, Inborn Errors | 1 | 2018 | 7 | 0.140 |
Why?
|
| Lymphoma, T-Cell | 1 | 2019 | 67 | 0.140 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2021 | 214 | 0.140 |
Why?
|
| Cell Differentiation | 1 | 2026 | 1935 | 0.140 |
Why?
|
| Arthralgia | 1 | 2018 | 79 | 0.140 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2019 | 216 | 0.130 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2019 | 189 | 0.130 |
Why?
|
| Tumor Escape | 1 | 2018 | 62 | 0.130 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2017 | 21 | 0.130 |
Why?
|
| Intellectual Disability | 2 | 2022 | 1080 | 0.130 |
Why?
|
| Leukemia | 1 | 2020 | 374 | 0.130 |
Why?
|
| Vesicular Transport Proteins | 1 | 2018 | 140 | 0.130 |
Why?
|
| Cytoskeletal Proteins | 1 | 2018 | 267 | 0.130 |
Why?
|
| Neutropenia | 1 | 2018 | 203 | 0.130 |
Why?
|
| Anemia, Aplastic | 1 | 2017 | 61 | 0.130 |
Why?
|
| Calreticulin | 1 | 2016 | 24 | 0.120 |
Why?
|
| Thrombopoietin | 1 | 2016 | 30 | 0.120 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2016 | 34 | 0.120 |
Why?
|
| Megakaryocytes | 1 | 2016 | 41 | 0.120 |
Why?
|
| Antigens, CD1 | 1 | 2016 | 23 | 0.120 |
Why?
|
| Thrombocythemia, Essential | 1 | 2016 | 33 | 0.120 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2022 | 575 | 0.120 |
Why?
|
| CD8 Antigens | 1 | 2016 | 38 | 0.120 |
Why?
|
| CD5 Antigens | 1 | 2016 | 33 | 0.120 |
Why?
|
| Infant | 9 | 2025 | 13299 | 0.110 |
Why?
|
| Immunophenotyping | 1 | 2016 | 330 | 0.110 |
Why?
|
| Flow Cytometry | 1 | 2017 | 771 | 0.110 |
Why?
|
| Janus Kinase 2 | 1 | 2016 | 138 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 901 | 0.110 |
Why?
|
| Metformin | 1 | 2016 | 171 | 0.110 |
Why?
|
| Thrombocytopenia | 1 | 2016 | 220 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 622 | 0.110 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 729 | 0.100 |
Why?
|
| Hemolysis | 2 | 2025 | 89 | 0.100 |
Why?
|
| Prognosis | 4 | 2019 | 4913 | 0.100 |
Why?
|
| Carcinogenesis | 1 | 2016 | 345 | 0.100 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 1612 | 0.100 |
Why?
|
| Genetic Therapy | 1 | 2018 | 720 | 0.090 |
Why?
|
| Male | 14 | 2025 | 64772 | 0.090 |
Why?
|
| Female | 14 | 2025 | 70560 | 0.090 |
Why?
|
| Child, Preschool | 6 | 2019 | 15018 | 0.090 |
Why?
|
| World Health Organization | 2 | 2022 | 114 | 0.090 |
Why?
|
| Mutation | 3 | 2022 | 6140 | 0.090 |
Why?
|
| Gene Expression | 1 | 2016 | 1492 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1318 | 0.080 |
Why?
|
| Inflammation | 1 | 2018 | 1478 | 0.080 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2018 | 949 | 0.080 |
Why?
|
| Adolescent | 7 | 2024 | 20820 | 0.080 |
Why?
|
| Young Adult | 3 | 2023 | 10042 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 4683 | 0.070 |
Why?
|
| Recurrence | 2 | 2025 | 1487 | 0.070 |
Why?
|
| Apoptosis | 2 | 2026 | 1844 | 0.070 |
Why?
|
| Syndrome | 2 | 2018 | 1162 | 0.060 |
Why?
|
| Receptors, Purinergic P2Y | 1 | 2025 | 6 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2024 | 1892 | 0.060 |
Why?
|
| Receptors, Cytokine | 1 | 2025 | 66 | 0.050 |
Why?
|
| Phenotype | 3 | 2018 | 4482 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2024 | 78 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2024 | 96 | 0.050 |
Why?
|
| Benzaldehydes | 1 | 2023 | 13 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2025 | 5199 | 0.050 |
Why?
|
| Adult | 4 | 2023 | 31245 | 0.050 |
Why?
|
| Pyrazines | 1 | 2023 | 79 | 0.050 |
Why?
|
| Bilirubin | 1 | 2023 | 126 | 0.050 |
Why?
|
| Haploidy | 1 | 2022 | 17 | 0.050 |
Why?
|
| CREB-Binding Protein | 1 | 2022 | 55 | 0.040 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2002 | 43 | 0.040 |
Why?
|
| Philadelphia Chromosome | 1 | 2021 | 41 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2022 | 150 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2022 | 144 | 0.040 |
Why?
|
| B7-H1 Antigen | 1 | 2022 | 132 | 0.040 |
Why?
|
| Laryngeal Neoplasms | 1 | 2002 | 86 | 0.040 |
Why?
|
| Ligands | 1 | 2022 | 486 | 0.040 |
Why?
|
| Germ Cells | 1 | 2022 | 200 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2023 | 358 | 0.040 |
Why?
|
| Middle Aged | 3 | 2018 | 28517 | 0.040 |
Why?
|
| Prevalence | 2 | 2017 | 2694 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2021 | 276 | 0.040 |
Why?
|
| Skin | 1 | 2022 | 543 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2022 | 576 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2019 | 76 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2026 | 1833 | 0.040 |
Why?
|
| Celecoxib | 1 | 2018 | 34 | 0.040 |
Why?
|
| Biopsy | 1 | 2022 | 1244 | 0.040 |
Why?
|
| Aged | 2 | 2016 | 20974 | 0.040 |
Why?
|
| Remission Induction | 1 | 2019 | 302 | 0.040 |
Why?
|
| Gene Rearrangement | 1 | 2020 | 326 | 0.040 |
Why?
|
| Acute Disease | 1 | 2021 | 1152 | 0.040 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2018 | 16 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2026 | 2031 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2025 | 8509 | 0.030 |
Why?
|
| Consanguinity | 1 | 2018 | 119 | 0.030 |
Why?
|
| Mice | 3 | 2022 | 18268 | 0.030 |
Why?
|
| Viral Matrix Proteins | 1 | 2018 | 108 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2019 | 319 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2018 | 362 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 1279 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2019 | 361 | 0.030 |
Why?
|
| Poly I-C | 1 | 2016 | 20 | 0.030 |
Why?
|
| Guanidines | 1 | 2016 | 21 | 0.030 |
Why?
|
| Inactivation, Metabolic | 1 | 2016 | 26 | 0.030 |
Why?
|
| Aldehydes | 1 | 2016 | 27 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2016 | 64 | 0.030 |
Why?
|
| Reticulin | 1 | 2016 | 8 | 0.030 |
Why?
|
| Bone Marrow Examination | 1 | 2016 | 14 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2019 | 17673 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 2115 | 0.030 |
Why?
|
| Chromosome Breakage | 1 | 2016 | 156 | 0.030 |
Why?
|
| Integrin beta3 | 1 | 2016 | 28 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2019 | 654 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2002 | 754 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 1088 | 0.030 |
Why?
|
| Genotype | 1 | 2022 | 2606 | 0.030 |
Why?
|
| Platelet Count | 1 | 2016 | 139 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 630 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2018 | 590 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2016 | 243 | 0.030 |
Why?
|
| Pedigree | 1 | 2018 | 1688 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2025 | 6450 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2016 | 602 | 0.030 |
Why?
|
| Animals | 3 | 2022 | 33982 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 2140 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 1623 | 0.020 |
Why?
|
| DNA Damage | 1 | 2016 | 517 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 702 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2022 | 2454 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2016 | 545 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2018 | 967 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2907 | 0.020 |
Why?
|
| Liver | 1 | 2019 | 1800 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2018 | 3836 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2018 | 2483 | 0.020 |
Why?
|
| Diet | 1 | 2016 | 1100 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2018 | 1265 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 6217 | 0.020 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2002 | 6 | 0.010 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2002 | 25 | 0.010 |
Why?
|
| Culture Techniques | 1 | 2002 | 74 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 12914 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2002 | 207 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2002 | 1501 | 0.010 |
Why?
|